Showing results (161-170 of 215) with videos related to
Sort By:
Pageof 22
Plos One|April 15, 2014
Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapyChristopher J Miller, Jason V Baker, Alison M Bormann, et al.The Lancet. Infectious Diseases|April 17, 2015
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study, Dianne Carey, Rebekah Puls, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2016
Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir-Ritonavir Plus Either Raltegravir or Tenofovir-Emtricitabine: A Substudy of the NEAT001/ANRS143 TrialAlan Winston, Wolfgang Stöhr, Andrea Antinori, et al.Translational Psychiatry|June 6, 2023
Biomarkers of central and peripheral inflammation mediate the association between HIV and depressive symptomsArish Mudra Rakshasa-Loots, Nicholas Bakewell, David J Sharp, et al.Antimicrobial Agents and Chemotherapy|May 11, 2016
Efavirenz and Metabolites in Cerebrospinal Fluid: Relationship with CYP2B6 c.516G→T Genotype and Perturbed Blood-Brain Barrier Due to Tuberculous MeningitisSam Nightingale, Tran Thi Hong Chau, Martin Fisher, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 5, 2016
Neurocognitive Function and Neuroimaging Markers in Virologically Suppressed HIV-positive Patients Randomized to Ritonavir-boosted Protease Inhibitor Monotherapy or Standard Combination ART: A Cross-sectional Substudy From the PIVOT TrialAlejandro Arenas-Pinto, Wolfgang Stöhr, Hans Rolf Jäger, et al.AIDS (London, England)|February 26, 2021
Agreement between self-reported and objective measures of sleep in people with HIV and lifestyle-similar HIV-negative individualsDavide De Francesco, Caroline A Sabin, Alan Winston, et al.AIDS (London, England)|June 15, 2021
The symptomatology of cerebrospinal fluid HIV RNA escape: a large case-seriesTerrence Y-H Chan, Valentina De Zan, Alistair Gregg, et al.International Journal of STD & AIDS|April 20, 2019
Cognitive function, depressive symptoms and syphilis in HIV-positive and HIV-negative individualsDavide De Francesco, Alan Winston, Jonathan Underwood, et al.Plos Pathogens|October 4, 2022
Enhanced immune responses following heterologous vaccination with self-amplifying RNA and mRNA COVID-19 vaccinesTamara Elliott, Hannah M Cheeseman, Abbey B Evans, et al.Pageof 22